REDMILE GROUP, LLC – TCR2 Therapeutics Inc. Transaction History
REDMILE GROUP, LLC portfolio value:
$1.97M
portfolio value
REDMILE GROUP, LLC quarter portfolio value change:
-37.93%
quarter
TCR2 Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1.20M | $1.8 | 1.09M | |
| Q2 2022 | share | 0.00% | 0 shares | 153K | $2.9 | 1.09M | |
| Q1 2022 | share | Decrease | -18.68% | -251.41K shares | -3.25M | $2.76 | 1.09M |
| Q4 2021 | share | Decrease | -64.73% | -2.47M shares | -26.20M | $4.79 | 1.34M |
| Q3 2021 | share | Increase | +17.95% | 580.9K shares | -20.62M | $8.51 | 3.81M |
| Q2 2021 | share | Decrease | -10.38% | -374.97K shares | -26.62M | $16.41 | 3.23M |
| Q1 2021 | share | Increase | +27.46% | 777.9K shares | -7.89M | $22.08 | 3.61M |
| Q4 2020 | share | Increase | +1.42% | 39.6K shares | 30.86M | $30.93 | 2.83M |
| Q3 2020 | share | Increase | +58.24% | 1.02M shares | 29.64M | $20.32 | 2.79M |
| Q2 2020 | share | Decrease | -0.12% | -2.1K shares | 13.43M | $15.36 | 1.76M |
| Q1 2020 | share | Decrease | -1.77% | -31.9K shares | -12.01M | $7.74 | 1.76M |
| Q4 2019 | share | Increase | +0.50% | 8.9K shares | -1.21M | $14.28 | 1.79M |
| Q3 2019 | share | Decrease | -0.50% | -8.92K shares | 1.16M | $15.03 | 1.79M |
| Q2 2019 | share | Decrease | -0.44% | -8.04K shares | -2.93M | $14.31 | 1.79M |
| Q1 2019 | share | Increase | 0.00% | 1.80M shares | 28.68M | $17.43 | 1.80M |